Enhertu has been recommended by NICE for NHS use in England, following an initial rejection due to cost in 2024.

INTRAVENOUS immunoglobulin showed favorable outcomes and was generally well tolerated across severe dermatologic diseases over 20 years. The real-world cohort study included 285 patients who received ...

In this episode, recorded at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026, we speak to Pooja Advani, ...

A Scandinavian study identifies major ketoacidosis risk factors among people with Type 2 diabetes receiving SGLT2 inhibitors.

Large Norwegian cohort finds no broad link between prenatal COVID-19 and neurodevelopmental disorders, but discover the one ...

A RANDOMISED clinical trial has shown that Desmodium styracifolium total flavone capsules, known as Guang Jing Qian Cao, ...

NHS patients in England can now access Enhertu, a breast cancer drug shown to extend survival by almost seven months.

HEPA air filtration was associated with faster cognitive test performance among adults aged 40 years and older. Read more.

An interpretable machine learning model predicted moderate to severe acute kidney injury risk in ICU patients with acute ...

MRI research links severe Type 2 asthma with differences in brain structure and white matter associated with inflammation ...

EMJ recently spoke to Derek Gilroy, Head of Department of Experimental & Translational Medicine, University College London, UK, about ...

Investigators compared 512 adult liver transplant recipients from a Danish nationwide comorbidity study with 2,010 age and sex matched participants from a general population cohort. Participants ...